PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models

Immunology-based interventions have been proposed as a promising curative chance to effectively attack postoperative minimal residual disease and distant metastatic localizations of prostate tumors. We developed a chimeric antigen receptor (CAR) construct targeting the human prostate-specific membra...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuccolotto, Gaia, Fracasso, Giulio, Merlo, Anna, Montagner, Isabella Monia, Rondina, Maria, Bobisse, Sara, Figini, Mariangela, Cingarlini, Sara, Colombatti, Marco, Zanovello, Paola, Rosato, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184866/
https://www.ncbi.nlm.nih.gov/pubmed/25279468
http://dx.doi.org/10.1371/journal.pone.0109427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184866/
https://www.ncbi.nlm.nih.gov/pubmed/25279468
http://dx.doi.org/10.1371/journal.pone.0109427

Ejemplares similares